Company: TBPH
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001104659-25-033819
Chunk: 41

Company: Theravance Biopharma, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 41
---
 annual general meeting. The standard annual award vests on the same dates as the automatic annual non-employee director grant described below. Automatic Annual Equity Awards At each annual general meeting (if applicable, upon each non-employee director’s re-election to our board of directors), each non-employee director is automatically granted the following equity awards: (i) a grant of RSUs covering ordinary shares with a grant date value of $100,000 and (ii) a nonstatutory share option grant with a Black-Scholes value of $125,000. These RSUs vest in full on the earlier of the one-year anniversary of the date of grant or the next annual general meeting, subject to continued service through such date. The share options vest monthly over the earlier of one year of service or the next annual general meeting. All automatic equity awards vest in full if we are subject to a change in control or the board member dies or becomes disabled while in service. Each share option granted pursuant to the automatic grant program has an exercise price equal to the fair market value of our ordinary shares on the date of grant, a term of up to ten years and remains exercisable for three years following termination of a director’s service other than for cause. Each RSU granted pursuant to the automatic grant program is settled by issuing our ordinary shares upon vesting and includes cash dividend equivalent rights in the event we pay any cash dividends to shareholders while the award is outstanding. In addition to the automatic equity awards described above, directors are also eligible to receive other equity awards under our 2013 Equity Incentive Plan (including the Amended and Restated 2013 Equity Plan after our 2023 Annual Meeting and, in either case, the “2013 Equity Incentive Plan”). 2024 Director Compensation Table The following table sets forth the compensation awarded to, earned by, or paid to each person who served as a director during 2024, other than a director who also served as a named executive officer.

| Name                          | ​ | ​ | Fees Earnedor Paid inCash($)(1) |   |        |   | ​ | ​ | ShareAwards($)(2)(3) |   |        |   | ​ | ​ | OptionAwards($)(2)(4) |   |         |   | ​ | ​ | Totals($) |   |         |   | ​ |
| (a)                           | ​ | ​ | -b                              |   |        |   | ​ | ​ | -c                   |